Headaches induced by overuse of analgesic and antimigraine drugs. Analysis of a cohort of 43 patients treated at a pain center in Saint-Etienne;Céphalées par abus des traitements symptomatiques antalgiques et anti-migraineux: Analyse des données recueillies, évaluation du vécu et de l'efficacité du sevrage effectué par 43 patients du centre anti-douleur de Saint-Etienne

Douleur et Analgesie

Volumn 15, Issue 3, 2002, Pages 115-124

  Taimi, C ^a   Navez, M ^a   Perrin, A M ^a   Laurent, B ^a  

^a CENTRE HOSPITALIER DE ROANNE   (France)

Author keywords

Coping; Drug inducedheadache; Life aspects; Withdrawal

Indexed keywords

ANTIMIGRAINE AGENT;

ADULT; ANALGESIA; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COPING BEHAVIOR; DRUG OVERDOSE; DRUG WITHDRAWAL; FEMALE; FRANCE; HEADACHE; HUMAN; MALE; MIGRAINE; PAIN; TREATMENT OUTCOME;

EID: 0041812921     PISSN: 1011288X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03008073     Document Type: Article

References (44)

1. Antonaci F.: Drug abuse headache: recognition and management. Cephalalgia 18, Suppl. 22, 47-55, 1998.
2. Baumgartner C., Wessely P., Bingöl C., Maly J. and Holzner F.: Long term prognosis of analgesic withdrawal in patients with drug-induced headache. Headache 29, 510-514, 1989.
3. Bes A.: Céphalées quotidiennes chroniques. Doul. et Anal. 1, 9-13, 1997.
4. Bowdler I., Kilian J. and Gansslen-Blumberg S.: The association between analgesic abuse and headache - Coincidental or causal. Letters to the editors. Headache 28 (7), 494, 1988.
5. Catarci T., Lenzi J.L., Cerbo R. and Fieschi C.: Sumatriptan and daily headache. J. Neurol. Neurosurg. Psychiatry 58, 508, 1995.
6. Devoize J.L., Pin J.C. et Hermosilla E.: Céphalées des antalgiques. Le concours médical 14 (6), 119-122, 1997.
7. Diener H.C., Haab J., Peters C., Ried S., Dichgans J. and Pilgrim A.: Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 31 (4), 205-209, 1991.
8. Diener H.C. and Tfelt-Hansen P.: Headache associated with chronic use of substances. In: Olesen J., The headaches, pp 721-727 Raven Press. New York, 1993.
9. Elkind A.H.: Drug abuse and headache. Med Clin. North Am. 75, 717-732, 1991.
10. Evers S., Schmidt F., Bauer B., Voss K.H. and Hussted I.W.: The impact of ergotamine-induced headache and ergotamine withdrawal on information processing. Psychopharmacology (Berl) 142, 61-67, 1999.
11. Gaist D., Tsiropoulos I., Sindrup S.H., Hallas J., Rasmussen B.K., Kragstrup J. and Gram L.F.: Inappropriate use of sumatriptan: population based register and interview study. BMJ 316, 1352-1353, 1998.
12. Goadsby P.J.: Sumatriptan is not the only analgesic used inappropriately. BMJ 317, (7164): 1016, 1998.
13. Gobel H., Stolze H., Heinze A. and Dworschaca M.: Easy therapeutical management of sumatriptan-induced daily headache. Neurology 47, 297-298, 1996.
14. Headache classification comittee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl.7), 19-28, 54-58, 1988.
15. Henry P., Brochet B. and Daubech J.F.: Aspects psychologiques des migraines et des céphalées. Doul. et Analg. 1, 21-26, 1997.
16. Hering R. and Steiner T.J.: Abrupt outpatient withdrawal of medication in analgesic abusing migraineurs. Lancet 337: 1442-1443, 1991.
17. Horowski R. and Ziegler A.: Possible pharmalogical mechanisms of chronic abuse of analgesics and other antimigraine drugs. Ed. by Diener H.C. and Wilkinson M. Drug-Induced Headache, pp. 96-104. Springer-Verlag Berlin Heidelberg, 1988.
18. Kaube H., May A. and Diener H.C.: Sumatriptan. BMJ 308, 1573-1574, 1994.
19. Lance F., Parkes C. and Wilkinson M.: Does analgesic abuse cause headaches de novo? Letters to the editors. Headache Feb., 61-62, 1988.
20. Legrain V. et Ophoven E.: Evaluation des facteurs psychologiques liés aux céphalées de tension: revue des instruments psychométriques. Doul. et Analg. 1, 101-110, 1999.
21. Limmroth V., Kazarawa Z., Fritsh G. and Diener H.C.: Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet 353, 378, 1999.
22. McAbee G.N.: Malpractrice risks associated with prescribing medication for chronic headache. Headache 38, 53-55, 1998.
23. Mathew N.T.: Chronic refractory headache. Neurology 43 (suppl. 3), S26-S33, 1993.
24. Mathew N.T.: Transformed migraine, analgesic rebound and other chronic daily headaches. Neurologic clinics 15 (1), 167-186, 1997.
25. Mathew N.T.: Medication misuse headache. Cephalalgia 18 (Suppl. 21), 34-36, 1998.
26. Mathew N.T., Kurman R. and Perez F. Drug induced refractory headache-clinical features and management. Headache 30 (10), 634-638, 1990.
27. Mignot G.: Céphalées induites par les antalgiques et les médicaments de l'accés migraineux. Revue prescrire 13 (126), 84-88, 1993.
28. Olesen J.: Analgesic headache. BMJ 310, 479-480, 1995.
29. Osborne M.J., Austin R.C.T., Dawson K.J. and Lange L.: Is there a problem with long term use of sumatriptan in acute migraine? BMJ 308, 113, 1994.
30. Pini L.A., Bigarelli M., Vital G. and Sternieri E. Headaches associated with chronic use of analgesics: a therapeutic approach. Headache 36 (7), 433-439, 1996.
31. Pini L.A. and Trenti T.: Does chronic use of sumatriptan induce dependence? Headache 34, 600, 1994.
32. Rapoport A., Stang P., Gutterman D.L., Cady R., Markley H., Weeks R., Saiers J. and Fox A.W. Analgesic rebound headache in clinical practice: data from a physician survey. Headache 36 (1), 14-19, 1996.
33. Rohr-Le Floch J. Céphalées chroniques par abus de médicaments: danger pour le migraineux. Schweiz Rundschau Med. (PRAXIS) 81 (47), 1417-1419, 1992.
34. Schnider P., Aull S., Baumgartner C., Marterer A., Wober C., Zeiler K. and Wessely P.: Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 16 (7), 481-485, 1996.
35. Silberstein S.D. and Young W.B.: Analgegic rebound headache. How great is the problem and what can be done. Drug Safety 13 (3), 133-144, 1995.
36. Silberstein S.D., Lipton R.B. and Sliwinski M.: Classification of daily and near daily headaches: field trial of revised IHS criteria. Neurology 47, 871-875, 1996.
37. Solomon S., Lipton R.B. and Newman L.C.: Clinical features of chronic daily headache. Headache 32, 325-329, 1992.
38. Suhr B., Evers S., Bauer B., Gralow I., Grotmeyer K.H. and Husstedt I.W.: Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 19 (1), 4449, 1999.
39. Taimi C., Navez M., Perrin A.M. et Laurent B.: Céphalées induites par l'abus des traitements symptomatiques antalgiques et antimigraineux. Revue Neurologique (publication acceptée prévue février ou mars 2001), 2001.
40. Touchon J.: Céphalées psychogenes. Doul. et Analg. 1, 15-20, 1997.
41. Visy J.M.: Céphalées de tension. Observatoire de la douleur 3, 32-36, 1999.
42. Violon A.: Psychologie des céphalalgiques. Petite contribution au grand chambardement. Doul et Anal. 4, 119-126, 1991.
43. Walker J., Parisi S. and Olive D.: Analgesic rebound headache: experience in a community hospital. South Med. J. 86 (11), 1202-1205, 1993.
44. Zed P.J., Loewen P.S. and Robinson G.: Medication-induced headache: overview and systematic review of therapeutic approaches. Ann. Pharmacother 33 (1), 61-72, 1999.